Received Mar 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
an expired dose of MenB (Bexsero) to a 17 year old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received Men B NVS (Bexsero) (expiry date 31-JAN-2026) for prophylaxis. On 08-MAR-2026, the patient received Bexsero. On 08-MAR-2026, an unknown time after receiving Bexsero, the patient experienced expired vaccine used (Verbatim: an expired dose of MenB (Bexsero) to a 17 year old patient). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 08-MAR-2026 Reporter stated that they gave an expired dose of MenB (Bexsero) to a 17 year old patient, he was monitored and there was no adverse reaction so far. The batch number was not provided upon follow- up with the reporter.